Cargando…

Fertility Sparing Treatment in Gastric-Type Endocervical Carcinoma

SIMPLE SUMMARY: Due to a trend toward late childbearing, fertility preservation has become a major issue in young patients with gynecological cancer. Surgical fertility sparing management is universally acknowledged as an acceptable option in eligible patients with cervical cancer. Excisional cone b...

Descripción completa

Detalles Bibliográficos
Autores principales: Rychlik, Agnieszka, Querleu, Denis, Bidzinski, Mariusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533748/
https://www.ncbi.nlm.nih.gov/pubmed/34680326
http://dx.doi.org/10.3390/cancers13205177
_version_ 1784587388188622848
author Rychlik, Agnieszka
Querleu, Denis
Bidzinski, Mariusz
author_facet Rychlik, Agnieszka
Querleu, Denis
Bidzinski, Mariusz
author_sort Rychlik, Agnieszka
collection PubMed
description SIMPLE SUMMARY: Due to a trend toward late childbearing, fertility preservation has become a major issue in young patients with gynecological cancer. Surgical fertility sparing management is universally acknowledged as an acceptable option in eligible patients with cervical cancer. Excisional cone biopsy or trachelectomy are now standard surgical procedures offered to selected patients with gynecological malignancies who wish to preserve their fertility. Neoadjuvant chemotherapy followed by surgery is another therapeutic option studied currently in numerous clinical trials. However, fertility preserving treatment is generally not recommended in rare histological types of cervical cancer, including clinically aggressive gastric-type endocervical carcinoma. Due to controversies in this emerging topic, a review of literature and international database was carried out, in search of solid evidence on fertility sparing management in gastric-type endocervical carcinoma. ABSTRACT: Fertility sparing management of cancer is one of the main components of quality-of-life issues. Early-stage cervical cancer, frequently diagnosed in women of reproductive age, can potentially be treated conservatively. However, some rare histological types of cervical cancer present with aggressive clinical behavior. Particularly, in the newly introduced concept of gastric-type endocervical carcinoma, fertility sparing management is ‘a priori’ not recommended. Even so, this issue remains undocumented. For this reason, a selected review of the current literature on gastric type endocervical carcinoma was carried out through PubMed. The keywords included “gastric-type cervical cancer”, “gastric-type endocervical carcinoma”, “conservative surgery”, “conservative treatment”, “fertility sparing surgery”, “radical trachelectomy”, “laparoscopic trachelectomy”, “robotic trachelectomy”, “laparotomic trachelectomy”, “abdominal trachelectomy”, “trachelectomy”, “neoadjuvant chemotherapy”, “conisation”, and “cone resection”. A search in the European Network on Cancer, Infertility and Pregnancy (INCIP) database was performed. The rarity of gastric-type endocervical carcinoma does not allow for conclusions on fertility sparing management with solid evidence. However, diffuse character of the disease and aggressive clinical behavior contraindicate a conservative treatment in young women with gastric type cervical cancer.
format Online
Article
Text
id pubmed-8533748
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85337482021-10-23 Fertility Sparing Treatment in Gastric-Type Endocervical Carcinoma Rychlik, Agnieszka Querleu, Denis Bidzinski, Mariusz Cancers (Basel) Review SIMPLE SUMMARY: Due to a trend toward late childbearing, fertility preservation has become a major issue in young patients with gynecological cancer. Surgical fertility sparing management is universally acknowledged as an acceptable option in eligible patients with cervical cancer. Excisional cone biopsy or trachelectomy are now standard surgical procedures offered to selected patients with gynecological malignancies who wish to preserve their fertility. Neoadjuvant chemotherapy followed by surgery is another therapeutic option studied currently in numerous clinical trials. However, fertility preserving treatment is generally not recommended in rare histological types of cervical cancer, including clinically aggressive gastric-type endocervical carcinoma. Due to controversies in this emerging topic, a review of literature and international database was carried out, in search of solid evidence on fertility sparing management in gastric-type endocervical carcinoma. ABSTRACT: Fertility sparing management of cancer is one of the main components of quality-of-life issues. Early-stage cervical cancer, frequently diagnosed in women of reproductive age, can potentially be treated conservatively. However, some rare histological types of cervical cancer present with aggressive clinical behavior. Particularly, in the newly introduced concept of gastric-type endocervical carcinoma, fertility sparing management is ‘a priori’ not recommended. Even so, this issue remains undocumented. For this reason, a selected review of the current literature on gastric type endocervical carcinoma was carried out through PubMed. The keywords included “gastric-type cervical cancer”, “gastric-type endocervical carcinoma”, “conservative surgery”, “conservative treatment”, “fertility sparing surgery”, “radical trachelectomy”, “laparoscopic trachelectomy”, “robotic trachelectomy”, “laparotomic trachelectomy”, “abdominal trachelectomy”, “trachelectomy”, “neoadjuvant chemotherapy”, “conisation”, and “cone resection”. A search in the European Network on Cancer, Infertility and Pregnancy (INCIP) database was performed. The rarity of gastric-type endocervical carcinoma does not allow for conclusions on fertility sparing management with solid evidence. However, diffuse character of the disease and aggressive clinical behavior contraindicate a conservative treatment in young women with gastric type cervical cancer. MDPI 2021-10-15 /pmc/articles/PMC8533748/ /pubmed/34680326 http://dx.doi.org/10.3390/cancers13205177 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Rychlik, Agnieszka
Querleu, Denis
Bidzinski, Mariusz
Fertility Sparing Treatment in Gastric-Type Endocervical Carcinoma
title Fertility Sparing Treatment in Gastric-Type Endocervical Carcinoma
title_full Fertility Sparing Treatment in Gastric-Type Endocervical Carcinoma
title_fullStr Fertility Sparing Treatment in Gastric-Type Endocervical Carcinoma
title_full_unstemmed Fertility Sparing Treatment in Gastric-Type Endocervical Carcinoma
title_short Fertility Sparing Treatment in Gastric-Type Endocervical Carcinoma
title_sort fertility sparing treatment in gastric-type endocervical carcinoma
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533748/
https://www.ncbi.nlm.nih.gov/pubmed/34680326
http://dx.doi.org/10.3390/cancers13205177
work_keys_str_mv AT rychlikagnieszka fertilitysparingtreatmentingastrictypeendocervicalcarcinoma
AT querleudenis fertilitysparingtreatmentingastrictypeendocervicalcarcinoma
AT bidzinskimariusz fertilitysparingtreatmentingastrictypeendocervicalcarcinoma